Designated Sublicensee definition

Designated Sublicensee is defined in Section 3.5.
Designated Sublicensee means any Sublicensee that Licensee and The Regents agree in writing is a Designated Sublicensee for the purposes of this Agreement.
Designated Sublicensee means any Sublicensee that Licensee and The Regents agree in writing is a Designated Sublicensee for the purposes of this Agreement. 2. Article 3 (Sublicenses) is amended to include a new Paragraph 3.6: 3.6 If this Agreement is terminated for any reason other than (a) [ * ], or (b) [ * ], in all cases except (a) and (b), Paragraph 3.5 will not apply, and instead this Paragraph 3.6 will apply: For as long as the Designated Sublicensee Agreement remains in effect, the Designated Sublicense will [ * ] and [ * ] on [ * ], and from and after the effective date of such termination with respect to Licensee, the Designated Sublicensee will be deemed to have [ * ] and will become [ * ] all of [ * ] and [ * ] that arise as a result of [ * ] by [ * ] of such [ * ], including all [ * ].

Examples of Designated Sublicensee in a sentence

  • Accordingly, in such case ▇▇▇▇▇▇▇ would not seek payment of any such [*] Payment from Rose U, and would instead seek payment from the subsequent Designated Sublicensee pursuant to the terms of the Subsequent Side Letter Agreement.

  • Each Party agrees (and Rose U agrees on behalf of each Designated Sublicensee) that all inventions, processes, materials, chemicals, know-how and ideas and all other business, technical and financial information it obtains from the other Party under this Agreement are the confidential property of the disclosing Party (“Confidential Information” of the disclosing Party).

  • Rose U shall contractually require Dermira to, and shall contractually require each subsequent Designated Sublicensee to, provide the same indemnity in favor of the Indemnified Persons as to each such Designated Sublicensee and its subsequent sublicensees.

  • Rose U shall promptly thereafter provide ▇▇▇▇▇▇▇ a true and correct copy of each such sublicense, provided that Rose U or the Designated Sublicensee may redact confidential provisions of the sublicense agreement that are not reasonably required for ▇▇▇▇▇▇▇ to confirm compliance with this Agreement (but not the identity of the Designated Sublicensee).

  • If the Rose U-Dermira Sublicense is terminated for any reason, then in the event that Rose U seeks to engage a subsequent Designated Sublicensee to replace Dermira, Rose U may request such subsequent Designated Sublicensee to enter into a letter agreement with ▇▇▇▇▇▇▇ substantially in the form of Exhibit B (a “Subsequent Side Letter Agreement”), with any changes made thereto only as ▇▇▇▇▇▇▇ finds acceptable.

  • An Indemnified Person shall reasonably promptly notify Rose U and any relevant Designated Sublicensee from which the Indemnified Person elects to seek indemnification under this Article 6 (each such Party, the “Indemnifying Party”) in writing, of any claim for which indemnification may be sought under this Article 6; provided however that any delay in notification shall not nullify any indemnification obligation except to the extent of actual prejudice.

  • If ▇▇▇▇▇▇▇ does elect to enter into a Subsequent Side Letter Agreement with such Designated Sublicensee, then the provisions of Section 4.3 herein shall continue to apply with the subsequent Designated Sublicensee replacing Dermira in such section of this Agreement.

  • In the event that ▇▇▇▇▇▇▇ declines to enter into the Subsequent Side Letter Agreement, Rose U may still elect to sublicense to such subsequent Designated Sublicensee but the provisions of Section 4.3 herein shall not apply and Rose U shall be liable to ▇▇▇▇▇▇▇ to make the [*] Payment.

  • No provision of this paragraph shall be interpreted to prevent Rose U or a Designated Sublicensee from making disclosures of Confidential Information to regulatory authorities as necessary: (i) for the research and development of Licensed Products; or (ii) to seek or obtain patents.

  • Medivation covenants and agrees that promptly following the Effective Date, it shall cause the Regents to agree in writing that for the purposes of the UCLA Agreement, as amended, Astellas is a Designated Sublicensee (as defined therein).